Patents by Inventor Marc Ayers

Marc Ayers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Controlled release pharmaceutical formulations of nitazoxanide
    Patent number: 11426388
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Grant
    Filed: July 2, 2019
    Date of Patent: August 30, 2022
    Assignee: Romark Laboratories L.C.
    Inventors: Jean-Francois Rossignol, Marc Ayers
  • CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS OF NITAZOXANIDE
    Publication number: 20190321338
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Application
    Filed: July 2, 2019
    Publication date: October 24, 2019
    Applicant: Rom ark Laboratories L. C.
    Inventors: Jean-Francois Rossignol, Marc Ayers
  • Controlled release pharmaceutical formulations of nitozoxanide
    Patent number: 10383855
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analog are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analog thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analog thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Grant
    Filed: November 16, 2017
    Date of Patent: August 20, 2019
    Assignee: Romark Laboratories L.C.
    Inventors: Jean-Francois Rossignol, Marc Ayers
  • CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS OF NITOZOXANIDE
    Publication number: 20180085353
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Application
    Filed: November 16, 2017
    Publication date: March 29, 2018
    Applicant: Romark Laboratories L.C.
    Inventors: Jean-Francois Rossignol, Marc Ayers
  • Controlled release pharmaceutical formulations of nitazoxanide
    Patent number: 9827227
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Grant
    Filed: April 29, 2016
    Date of Patent: November 28, 2017
    Assignee: Romark Laboratories L.C.
    Inventors: Jean-Francois Rossignol, Marc Ayers
  • CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS OF NITAZOXANIDE
    Publication number: 20160243087
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Application
    Filed: April 29, 2016
    Publication date: August 25, 2016
    Applicant: Romark Laboratories L.C.
    Inventors: Jean-Francois Rossignol, Marc Ayers
  • Controlled release pharmaceutical formulations of nitazoxanide
    Patent number: 9351937
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analog are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analog thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analog thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Grant
    Filed: July 30, 2013
    Date of Patent: May 31, 2016
    Assignee: Romark Laboratories L.C.
    Inventors: Jean-Francois Rossignol, Marc Ayers
  • CONTROLLED RELEASE PHARMACEUTICAL FORMULATIONS OF NITAZOXANIDE
    Publication number: 20140065215
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Application
    Filed: July 30, 2013
    Publication date: March 6, 2014
    Applicant: Romark Laboratories L.C.
    Inventors: Jean-Francois Rossignol, Marc Ayers
  • Controlled release pharmaceutical formulations of nitazoxanide
    Patent number: 8524278
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Grant
    Filed: February 12, 2010
    Date of Patent: September 3, 2013
    Assignee: Romark Laboratories L.C.
    Inventors: Jean-Francois Rossignol, Marc Ayers
  • Controlled release pharmaceutical formulations of nitazoxanide
    Publication number: 20100209505
    Abstract: Solid dosage formulations of nitazoxanide or a nitazoxanide analogue are provided that comprise a controlled release portion and an immediate release portion. The pharmaceutical composition is typically in the form of a bilayer solid oral dosage form comprising (a) a first layer comprising a first quantity of nitazoxanide or analogue thereof in a controlled release formulation; and (b) a second layer comprising a second quantity of nitazoxanide or analogue thereof in an immediate release formulation. Method of using the formulations in the treatment of hepatitis C are also provided.
    Type: Application
    Filed: February 12, 2010
    Publication date: August 19, 2010
    Inventors: Jean-Francois Rossignol, Marc Ayers